India's Hikal drops on US FDA warning letter, potential revenue delay

Hikal

29/09/2025 08:38

** Shares of Hikal Ltd HIKA.NS drop 2.4% to 249 rupees, down for a sixth consecutive session

** The pharmaceutical ingredients maker disclosed a warning letter on Friday from the U.S. FDA for "inadequate investigations of customer complaints on foreign matter"

** HIKA flags potential delay of revenue flow into second half of fiscal 2026

** Co adds that it has taken corrective actions and informed the U.S. FDA of the same

** Stock down 36% so far this year

 (Reporting by Nandan Mandayam in Bengaluru)

 ((Nandan.Mandayam@thomsonreuters.com; Mobile: +91 9591011727;))